WATCH: An INQside Look with vaccine expert Dr. Lulu Bravo | Inquirer News

WATCH: An INQside Look with vaccine expert Dr. Lulu Bravo

/ 10:00 AM April 16, 2021

MANILA, Philippines — More than 1.2 million doses of the COVID-19 vaccine were already dispensed to priority recipients nationwide as of April 13. Still, many people remain in doubt about the safety and efficacy of the shots against the deadly respiratory disease.

In view of the common goal to achieve herd immunity, what can the government and health experts do to allay people’s COVID-19 vaccination fears?

INQUIRER.net speaks with Dr. Lulu Bravo, executive director of the Philippine Foundation for Vaccination and chairperson of the National Adverse Events Following Immunization Committee, to delve into the adverse or unwanted secondary effects of vaccine and more.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Coronavirus, coronavirus Philippines, COVID-19, COVID-19 Vaccine, Health, inqside look, pandemic, SARS-CoV-2, side effects, vaccine, Virus

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.